Actuate Therapeutics, Inc.
ACTU
$7.35
-$0.08-1.08%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.41M | -5.95M | -6.32M | -6.45M | -5.97M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.81M | 1.58M | 1.13M | 1.20M | 1.22M |
| Change in Net Operating Assets | -3.08M | 191.30K | 568.10K | 477.00K | -4.40M |
| Cash from Operations | -6.68M | -4.17M | -4.62M | -4.77M | -9.15M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | 0.00 | 200.00K |
| Total Debt Repaid | -- | -- | -- | 0.00 | -200.00K |
| Issuance of Common Stock | 16.82M | 7.21M | -- | 0.00 | 23.96M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 289.50K | -429.50K | -133.50K | -109.40K | -1.64M |
| Cash from Financing | 17.11M | 6.78M | -133.50K | -109.40K | 22.32M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.43M | 2.60M | -4.75M | -4.88M | 13.17M |